IPSEN (EPA:IPN) | WebDisclosure

Basculer en Français

10742	Companies
230462	Keywords
158888	Articles
122433	Press releases

Home
Companies
IPSEN

PRESS RELEASE

published on 09/16/2024 at 14:45, 1 year 10 months ago

Les résultats finaux de l’essai de Phase III CABINET corroborent les bénéfices en termes d’efficacité de Cabometyx® dans les tumeurs neuroendocrines avancées
Les résultats finaux de l’essai de Phase III CABINET confirment l’efficacité de Cabometyx dans les tumeurs neuroendocrines avancées. Ipsen publie les données au congrès ESMO 2024

Essai Clinique Ipsen Tumeurs Neuroendocrines ESMO 2024 Cabometyx
PRESS RELEASE

published on 09/16/2024 at 14:45, 1 year 10 months ago

Final results from CABINET Phase III trial reinforce efficacy benefits of Cabometyx® in advanced neuroendocrine tumors
Final results from CABINET Phase III trial show significant reduction in disease progression or death risk with Cabometyx in advanced neuroendocrine tumors. Data presented at ESMO 2024 and NEJM

Phase III Trial Neuroendocrine Tumors ESMO 2024 Cabometyx Disease Progression
BRIEF

published on 09/15/2024 at 14:50, 1 year 10 months ago

New analysis of the CONTACT-02 trial by Ipsen

Clinical Trial Ipsen Prostate Cancer CONTACT-02 Cabometyx
BRIEF

published on 09/15/2024 at 14:50, 1 year 10 months ago

Nouvelle analyse de l'essai CONTACT-02 par Ipsen

Essai Clinique Ipsen Cancer De La Prostate CONTACT-02 Cabometyx
PRESS RELEASE

published on 09/15/2024 at 14:45, 1 year 10 months ago

Ipsen communique de nouvelles données sur l’essai de Phase III CONTACT-02 dans le cancer de la prostate métastatique résistant à la castration au terme de l’analyse finale de la survie globale
Ipsen communique de nouvelles données sur l’essai de Phase III CONTACT-02 dans le cancer de la prostate métastatique résistant à la castration, montrant une amélioration de la survie globale avec Cabometyx et atézolizumab

Ipsen Cabometyx Cancer De La Prostate Métastatique Essai De Phase III Survie Globale
PRESS RELEASE

published on 08/13/2024 at 18:00, 1 year 11 months ago

IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 32 - 2024
PRESS RELEASE

published on 08/13/2024 at 18:00, 1 year 11 months ago

IPSEN - Buy-back programme - Art 5 of MAR - Week 32 - 2024
BRIEF

published on 05/28/2024 at 07:05, 2 years 1 month ago

Ipsen Announces Share Repurchase Program Details

Annual General Meeting Share Repurchase Corporate Governance Investment Stock Buyback
BRIEF

published on 05/28/2024 at 07:05, 2 years 1 month ago

Ipsen Proposes Share Repurchase Program at Annual General Meeting

Annual General Meeting French Commercial Code Share Repurchase Stock Buyback Ipsen
BRIEF

published on 05/28/2024 at 07:05, 2 years 1 month ago

Ipsen propose un programme de rachat d'actions à l'Assemblée générale annuelle

Rachat D'actions Assemblée Générale Annuelle Code De Commerce Français Ipsen

Accesswire

Published on 07/17/2026 at 15:00, 1 day 12 hours ago

Four Nines Gold to Showcase Hayden Hill Opportunity to U.S. Investors at OTC Markets Virtual Investor Conference
Published on 07/17/2026 at 14:00, 1 day 13 hours ago

Redwood AI Announces Pricing of $3.5 Million Private Placement
Published on 07/17/2026 at 13:00, 1 day 14 hours ago

Blue Lagoon Surpasses $10 Million In Revenue As Dome Mountain Production Rises To 125 Tonnes Per Day
Published on 07/17/2026 at 01:00, 2 days 2 hours ago

RJK Explorations Ltd. Announces Closing of Private Placement for Gross Proceeds of $310,000
Published on 07/17/2026 at 00:00, 2 days 3 hours ago

LIR Life Sciences Signs Development Services Agreement with Oxygen Handel GmbH (OH) to Advance Regulatory and Preclinical Roadmap for Transdermal Obesity Pipeline

View all ACCESSWIRE

EQS Group

Published on 07/18/2026 at 08:00, 19 hours 26 minutes ago

Northern Data AG – Changes to the Supervisory Board and the Management Board
Published on 07/17/2026 at 20:35, 1 day 6 hours ago

Farizon Opens Global Spare Part Distribution Center to Strengthen International Aftersales Support
Published on 07/17/2026 at 18:55, 1 day 8 hours ago

CGTN: China vows to make AI a driver for shared prosperity amid widening AI divide
Published on 07/17/2026 at 18:45, 1 day 8 hours ago

NNS acquires shares in OCI
Published on 07/17/2026 at 18:32, 1 day 8 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 07/17/2026 at 18:31, 1 day 8 hours ago

Déclaration hebdomadaire d'opérations effectuées du 13 au 17 juillet 2026
Published on 07/17/2026 at 18:31, 1 day 8 hours ago

Disclosure of transactions in own shares from July 13 to July 17, 2026
Published on 07/17/2026 at 18:00, 1 day 9 hours ago

Information regarding compliance with gender balance rules within the Board of Directors
Published on 07/17/2026 at 18:00, 1 day 9 hours ago

Informations relatives au respect des règles de représentation équilibrée au sein du Conseil d’administration
Published on 07/17/2026 at 17:45, 1 day 9 hours ago

Imerys-07-2026-information-share-capital-and-voting-rights-as-of-30-June-2026

View all LES ECHOS COMFI WIRE